Rhodes, S., Short, S., Sharma, S., Kaur, R., & Jha, M. (2019). One-pot mild and efficient synthesis of [1,3]thiazino[3,2-a]indol-4-ones and their anti-proliferative activity. Org Biomol Chem, 17(16), 3914-3920.
Mittal K, Donthamsetty S, Kaur R, et al. 2017. Multinucleated polyploidy drives resistance to Docetaxel chemotherapy in prostate cancer. British Journal of Cancer 116(9):1186-1194.
Mittal K, Choi DH, Klimov S, Pawar S, Kaur R, et al. 2016. A centrosome clustering protein, KIFC1, predicts aggressive disease course in serous ovarian
adenocarcinomas. J Ovarian Res 18(9):17.
Shashidharamurthy R, Bozeman EN, Patel J, Kaur R, et al. 2012. Immunotherapeutic strategies for cancer treatment: A novel protein transfer approach for cancer vaccine development. Medicinal Research Reviews 32(6):1197-219.
Engelman JA, Chen L, Tan X, Crosby K, Guimaraes AR, Upadhyay R, Maira M, McNamara K, Perera SA, Song Y, Chirieac LR, Kaur R, et al. 2008. Effective use of PI3K and MEK inhibitors to treat mutant K-Ras G12D and PIK3CA H1047R murine lung cancers. Nat Med.14(12):1351-6.
Kaur R, Yuan X, Lu ML, Balk SP. 2008. Increased PAK6 expression in prostate cancer and identification of PAK6 associated proteins. Prostate 68(14):1510-6.